Frequently Asked Questions — Developing Potential Cellular and Gene Therapy Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 18, 2024
November 25, 2024
18812f43-d054-46e4-b040-2e02c42fb4a3
Related Documents
Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria: Draft Guidance for Industry
Guidance DocumentJanuary 15, 2025Center for Biologics Evaluation and Research
Potency Assurance for Cellular and Gene Therapy Products
Guidance DocumentDecember 27, 2023Center for Biologics Evaluation and Research
Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products
Guidance DocumentJuly 13, 2023Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.